Media coverage about Neovasc Inc (US) (NASDAQ:NVCN) (TSE:NVC) has trended somewhat positive recently, Accern Sentiment reports. Accern identifies positive and negative media coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Neovasc Inc (US) earned a news sentiment score of 0.24 on Accern’s scale. Accern also assigned media coverage about the medical equipment provider an impact score of 45.9140264862528 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

These are some of the news headlines that may have impacted Accern’s scoring:

A number of equities analysts have recently commented on NVCN shares. ValuEngine lowered shares of Neovasc Inc (US) from a “sell” rating to a “strong sell” rating in a research report on Sunday, December 31st. Canaccord Genuity restated a “buy” rating and issued a $1.05 price objective on shares of Neovasc Inc (US) in a research report on Friday, January 19th. Finally, Zacks Investment Research lowered shares of Neovasc Inc (US) from a “hold” rating to a “sell” rating in a research report on Wednesday, January 31st. Two equities research analysts have rated the stock with a sell rating and four have issued a buy rating to the stock. Neovasc Inc (US) has a consensus rating of “Hold” and an average target price of $2.95.

Neovasc Inc (NASDAQ:NVCN) traded up $0.01 during mid-day trading on Monday, hitting $0.21. 13,652,955 shares of the stock were exchanged, compared to its average volume of 3,992,825. Neovasc Inc has a one year low of $0.19 and a one year high of $2.12. The company has a market capitalization of $20.61, a price-to-earnings ratio of 0.78 and a beta of 1.86.

WARNING: This piece of content was originally posted by Daily Political and is the sole property of of Daily Political. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this piece of content can be accessed at

About Neovasc Inc (US)

Neovasc Inc (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company’s segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products.

Insider Buying and Selling by Quarter for Neovasc Inc (US) (NASDAQ:NVCN)

Receive News & Ratings for Neovasc Inc (US) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neovasc Inc (US) and related companies with's FREE daily email newsletter.